BeiGene Ltd (BGNE)

167.90 +3.46 (+2.10%) USD  |  NASDAQ  |  May 09, 12:53
More

BeiGene Debt to Equity Ratio: 0.2505 for Dec. 31, 2023

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2014. Upgrade now.
Date Value
December 31, 2023 0.2505
September 30, 2023 0.1411
June 30, 2023 0.1655
March 31, 2023 0.1174
December 31, 2022 0.1228
September 30, 2022 0.1395
June 30, 2022 0.1067
March 31, 2022 0.1035
December 31, 2021 0.1027
September 30, 2021 0.1916
June 30, 2021 0.1746
March 31, 2021 0.1494
December 31, 2020 0.134
September 30, 2020 0.0471
June 30, 2020 0.1253
March 31, 2020 0.0891
December 31, 2019 0.2501
September 30, 2019 0.20
June 30, 2019 0.1593
Date Value
March 31, 2019 0.1502
December 31, 2018 0.1141
September 30, 2018 0.0995
June 30, 2018 0.1729
March 31, 2018 0.1292
December 31, 2017 0.2459
September 30, 2017 0.2111
June 30, 2017 0.5972
March 31, 2017 0.0645
December 31, 2016 0.049
September 30, 2016 0.096
June 30, 2016 0.048
March 31, 2016 0.0256
December 31, 2015 0.2797
September 30, 2015 0.2061
June 30, 2015 0.1278
March 31, 2015
December 31, 2014 0.537

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

0.0471
Minimum
Sep 2020
0.2505
Maximum
Dec 2023
0.1458
Average
0.1395
Median
Sep 2022

Debt to Equity Ratio Benchmarks

Theravance Biopharma Inc 0.00
LumiraDx Ltd -1.741
Dr Reddy's Laboratories Ltd 0.0585
ASLAN Pharmaceuticals Ltd --
Zai Lab Ltd 0.00

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 5.805B
Total Liabilities (Quarterly) 2.268B
Shareholders Equity (Quarterly) 3.537B
Current Ratio 2.322
Net Debt Paydown Yield -0.25%